Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$15.57 - $17.11 $1.62 Million - $1.78 Million
-104,100 Reduced 80.64%
25,000 $392,000
Q1 2023

May 15, 2023

BUY
$15.28 - $16.48 $1.97 Million - $2.13 Million
129,100 New
129,100 $2.13 Million
Q3 2022

Nov 14, 2022

BUY
$12.8 - $28.65 $11.3 Million - $25.3 Million
884,500 New
884,500 $11.5 Million
Q3 2021

Nov 15, 2021

BUY
$16.3 - $17.26 $578,650 - $612,730
35,500 New
35,500 $581,000

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $41.5B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.